PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        The US

·        China

·        Europe

·        Japan

·        Singapore

Key Regulatory Paths ·        PMA

·        NMPA

·        CE

·        Shonin

·        De novo

Leading Companies ·        Aachen Resonance GmbH

·        Acotec Scientific Co Ltd

·        Advanced NanoTherapies Inc

·        B. Braun Interventional Systems Inc

·        Boston Scientific Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Segmentation by Territories

A few of the key territories for the PTCA Drug Coated Balloon (DCB) Catheters pipeline market are the US, China, Europe, Japan, and Singapore. As of March 2024, the US accounted for the highest number of pipeline products.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Territories, 2024 (%)

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market

Download a Free Report Sample

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the PTCA Drug Coated Balloon (DCB) Catheters pipeline products market are PMA, NMPA, CE, Shonin, and De novo. As of March 2024, PMA was the most followed pathway for pipeline products in the market.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market

Download a Free Report Sample

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market – Competitive Landscape

A few of the key companies associated with the PTCA Drug Coated Balloon (DCB) Catheters pipeline market are Aachen Resonance GmbH, Acotec Scientific Co Ltd, Advanced NanoTherapies Inc, B. Braun Interventional Systems Inc and Boston Scientific Corp among others.

Acotec Scientific Co Ltd: Acotec Scientific Co Ltd, a subsidiary of Acotec Scientific Holdings Ltd, is a research and development firm that offers medical devices such as electro physiologic catheters, drug coated balloons, percutaneous transluminal angioplasty, and vascular interventional treatments. The company is headquartered in Beijing, China.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Companies, 2024

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Japan
  • Singapore

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Regulatory Paths Outlook

  • PMA
  • NMPA
  • CE
  • Shonin
  • De novo

Scope

This report provides:

  • Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aachen Resonance GmbH
Acotec Scientific Co Ltd
Advanced NanoTherapies Inc
B. Braun Interventional Systems Inc
Boston Scientific Corp
Caliber Therapeutics, Inc.
Chansu Vascular Technologies LLC
Concept Medical Inc
Cordis US Corp
Dongguan TT Medical Inc
Innova Vascular Inc
Jiwei Medical System Ltd
Lepu Medical Technology (Beijing) Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
Medtronic Plc
MicroPort Scientific Corp
OrbusNeich
Orchestra BioMed Inc
QT Vascular Ltd
Rontis Hellas SA
Shanghai MicroPort Medical Group Co Ltd
Shanghai XinZhi Medical Technology Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Spectranetics Corp
Vascular Nanotransfer Technologies

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 9

2 Introduction 10

2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview 10

3 Products under Development 11

3.1 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 11

3.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory 12

3.3 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path 13

3.4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date 14

3.5 PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials 15

4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products under Development by Companies 16

4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies – Pipeline Products by Stage of Development 16

4.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 18

5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview 20

5.1 Aachen Resonance GmbH Company Overview 20

5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Acotec Scientific Co Ltd Company Overview 21

5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Advanced NanoTherapies Inc Company Overview 24

5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 B. Braun Interventional Systems Inc Company Overview 28

5.4.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Boston Scientific Corp Company Overview 34

5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Caliber Therapeutics, Inc. Company Overview 40

5.6.1 Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.7 Chansu Vascular Technologies LLC Company Overview 41

5.7.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.8 Concept Medical Inc Company Overview 44

5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.9 Cordis US Corp Company Overview 50

5.9.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview 50

5.10 Dongguan TT Medical Inc Company Overview 51

5.10.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.11 Innova Vascular Inc Company Overview 52

5.11.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.12 Jiwei Medical System Ltd Company Overview 53

5.12.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview 54

5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 58

5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.15 Medtronic Plc Company Overview 59

5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 MicroPort Scientific Corp Company Overview 63

5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 63

5.17 OrbusNeich Company Overview 64

5.17.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 64

5.18 Orchestra BioMed Inc Company Overview 65

5.18.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.19 QT Vascular Ltd Company Overview 69

5.19.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.20 Rontis Hellas SA Company Overview 70

5.20.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview 70

5.21 Shanghai MicroPort Medical Group Co Ltd Company Overview 71

5.21.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

5.22 Shanghai XinZhi Medical Technology Co Ltd Company Overview 72

5.22.1 Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview 73

5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.24 Spectranetics Corp Company Overview 75

5.24.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 75

5.25 Vascular Nanotransfer Technologies Company Overview 76

5.25.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 76

6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments 78

6.1 Mar 13, 2024: Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting 78

6.2 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 79

6.3 Mar 10, 2024: Boston Scientific Receives Pre-Market Approval For Agent Paclitaxel Coated-PTCA Balloon Catheter 79

6.4 Mar 01, 2024: FDA approves Boston Scientific’s drug-coated balloon 79

6.5 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 80

6.6 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 80

6.7 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 80

6.8 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 80

6.9 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1 82

6.10 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 82

6.11 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 83

6.12 Oct 25, 2023: Boston Scientific AGENT Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial 84

6.13 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 85

6.14 Sep 15, 2023: MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study 86

6.15 Sep 06, 2023: MedAlliance Announces Enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study 87

6.16 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 87

6.17 Aug 08, 2023: Orchestra Biomed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue Sirolimus Angioinfusion Balloon in Patients With Coronary In-Stent Restenosis 88

6.18 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 89

6.19 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 89

6.20 May 30, 2023: Concept Medical’s MagicTouch PTA receives FDA approval to treat SFA 89

6.21 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 90

6.22 May 01, 2023: Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease 90

6.23 Apr 12, 2023: Medtronic has a layoff in California 91

7 Appendix 92

7.1 Methodology 92

7.2 About GlobalData 95

7.3 Contact Us 95

7.4 Disclaimer 95

Table

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 11

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory 12

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path 13

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date 14

PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials 15

PTCA Drug Coated Balloon (DCB) Catheters Companies – Pipeline Products by Stage of Development 16

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 18

Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

VIAR – Product Status 20

VIAR – Product Description 20

Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

ACOART Sirolimus Coated Balloon Catheter – Product Status 21

ACOART Sirolimus Coated Balloon Catheter – Product Description 21

Acotec Scientific Co Ltd – Ongoing Clinical Trials Overview 22

ACOART Sirolimus Coated Balloon Catheter – A Prospective, Multicenter, Random Controlled Clinical Trail to Evaluate the Effectiveness and Safety of Sirolimus Coated Balloon Versus a Paclitaxel Coated Balloon in the Treatment of Coronary Bifurcation Lesion 23

ACOART Sirolimus Coated Balloon Catheter – A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety Between Sirolimus Coated Balloon Catheter and Paclitaxel Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis 23

Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Sirolimus Coated Angioplasty Balloon – Product Status 24

Sirolimus Coated Angioplasty Balloon – Product Description 24

SirPlux Duo Drug-Coated Balloon – Product Status 25

SirPlux Duo Drug-Coated Balloon – Product Description 25

Advanced NanoTherapies Inc – Ongoing Clinical Trials Overview 26

SirPlux Duo Drug-Coated Balloon – A Prospective, Single-arm, Multi-center, Feasibility First-in-human Study to Evaluate Safety and Performance of the SirPlux Duo Dual-API Coated PTCA Balloon Catheter to Treat De-novo Lesions in Patients With Symptomatic Stable Coronary Artery Disease 27

B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 28

SeQuent Please – Product Status 28

SeQuent Please – Product Description 28

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – Product Status 29

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – Product Description 29

B. Braun Interventional Systems Inc – Ongoing Clinical Trials Overview 30

SeQuent Please – A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the Intracranial Paclitaxel Drug-eluting Balloon Catheters (SeQuent Please CIS) in the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis and Restenosis after Interventional Therapy 31

SeQuent Please – A Prospective, Randomized, Non-inferiority Trial to Determine the Safety and Efficacy of the BA9 Drug Coated Balloon for the Treatment of In-stent Restenosis: First-in-man Trial: REFORM 31

SeQuent Please – Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI 31

SeQuent Please – Drug-coating Balloon Treatment in Coronary Artery Disease: A Prospective, Multicenter, Registry Study (ULTIMATE-DCB) 32

SeQuent Please – To Evaluate the Long Term Safety and Efficacy of Drug Coated Balloon SeQuent Please in Chinese Coronary Instent Restenosis Patients, a Prospective, Multi-center, Randomization Clinical Trial 32

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Paclitaxel Balloon Dilator Versus Paclitaxel Releasing Coronary Balloon Catheter in the Treatment of in Stent Restenosis (ISR) 33

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Agent Paclitaxel Coated-PTCA Balloon Catheter – Product Status 34

Agent Paclitaxel Coated-PTCA Balloon Catheter – Product Description 35

Agent Paclitaxel Coated-PTCA Balloon Catheter – Acute Coronary Syndrome – Product Status 35

Agent Paclitaxel Coated-PTCA Balloon Catheter – Acute Coronary Syndrome – Product Description 35

Agent Paclitaxel Coated-PTCA Balloon Catheter – Bifurcations – Product Status 36

Agent Paclitaxel Coated-PTCA Balloon Catheter – Bifurcations – Product Description 36

Agent Paclitaxel Coated-PTCA Balloon Catheter – Small Vessel – Product Status 36

Agent Paclitaxel Coated-PTCA Balloon Catheter – Small Vessel – Product Description 37

Boston Scientific Corp – Ongoing Clinical Trials Overview 38

Agent Paclitaxel Coated-PTCA Balloon Catheter – AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects with In-Stent Restenosis (ISR) 39

Agent Paclitaxel Coated-PTCA Balloon Catheter – Intracoronary Stenting and Restenosis – Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 39

Agent Paclitaxel Coated-PTCA Balloon Catheter – Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease 39

Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

TADD Device – Product Status 40

TADD Device – Product Description 40

Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 41

Coronary Everolimus Drug-Coated Balloon – Product Status 41

Coronary Everolimus Drug-Coated Balloon – Product Description 41

Chansu Vascular Technologies LLC – Ongoing Clinical Trials Overview 42

Coronary Everolimus Drug-Coated Balloon – Everolimus-Coated Percutaneous Transluminal Coronary Angioplasty Catheter First in Human Clinical Investigation: A Clinical Evaluation in the Treatment of Subjects with In-Stent Restenosis of Previously-treated Coronary Artery Lesions 43

Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

MagicTouch Sirolimus Coated Balloon Catheter – Product Status 44

MagicTouch Sirolimus Coated Balloon Catheter – Product Description 44

Concept Medical Inc – Ongoing Clinical Trials Overview 45

MagicTouch Sirolimus Coated Balloon Catheter – A Pivotal Study to Support Safety and Efficacy of MagicTouch Sirolimus Coated Balloon for In-stent Restenosis 46

MagicTouch Sirolimus Coated Balloon Catheter – A Study to Evaluate Safety and Effectiveness of the MagicTouch SCB in Small Vessel Coronary Disease Subjects 46

MagicTouch Sirolimus Coated Balloon Catheter – Angiographic Performance Following PCI with A Sirolimus-eluting Balloon in the Treatment of De Novo Coronary Artery Disease: GINGER Study 46

MagicTouch Sirolimus Coated Balloon Catheter – Bifurcation PCI With a Hybrid Strategy with Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy. A Randomized Controlled Trial and Registry 47

MagicTouch Sirolimus Coated Balloon Catheter – Evaluate the Performance of a Sirolimus-Eluting Drug-Coated Balloon (SCB) For the Treatment of Any Coronary Lesions, Including De Novo Lesions and In-Stent Restenosis 47

MagicTouch Sirolimus Coated Balloon Catheter – Magic Touch Sirolimus Coated Balloon (Concept Medical) Versus SeQuent Please Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Small Vessels 47

MagicTouch Sirolimus Coated Balloon Catheter – Paclitaxel- or Sirolimus-Coated Balloons Used For Arteriovenous Fistulas – 2 (Pave-2 Trial): A Double-Blind Randomized Controlled Clinical Trial to Determine the Efficacy of Paclitaxel- or Sirolimus-Coated Balloons in Arteriovenous Fistulas for Haemodialysis 48

MagicTouch Sirolimus Coated Balloon Catheter – Prospective Multi-center Randomized Controlled Trial to Evaluate the Safety and Efficacy of Sirolimus Drug Coated Balloon Versus Non-coated Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with Peripheral Arterial Disease 48

MagicTouch Sirolimus Coated Balloon Catheter – Sirolimus Drug-coated Balloon Versus Stent Graft for Thrombosed Arteriovenous Graft (SUSTAIN) 48

MagicTouch Sirolimus Coated Balloon Catheter – Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels 49

MagicTouch Sirolimus Coated Balloon Catheter – TicIn for the Treatment of coronAry lesioNs With Drug Eluting Balloons 49

Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview 50

SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter – Coronary In-Stent Restenosis – Product Status 50

SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter – Coronary In-Stent Restenosis – Product Description 50

Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 51

EverFlow Sirolimus Coated PTCA Balloon Catheter – Product Status 51

EverFlow Sirolimus Coated PTCA Balloon Catheter – Product Description 51

Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Drug Coated Balloon – Product Status 52

Drug Coated Balloon – Product Description 52

Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

Umimus Coated Coronary Artery Balloon Dilatation Catheter – Product Status 53

Umimus Coated Coronary Artery Balloon Dilatation Catheter – Product Description 53

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

Vesselin Drug Coated Coronary Balloon Catheter – Product Status 54

Vesselin Drug Coated Coronary Balloon Catheter – Product Description 55

Lepu Medical Technology (Beijing) Co Ltd – Ongoing Clinical Trials Overview 56

Vesselin Drug Coated Coronary Balloon Catheter – Assess the Safety and Efficacy of Lepu Drug Coated Balloon Versus Restore Paclitaxel Eluting Balloon for the Treatment of Coronary Small-vessel Disease: A Prospective, Multicenter, Randomized, Controlled Trial 57

Vesselin Drug Coated Coronary Balloon Catheter – Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions: an Open-label, Multicenter, Randomized, Non-inferiority Trial 57

Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

PTCA Drug Eluting Balloon – Product Status 58

PTCA Drug Eluting Balloon – Product Description 58

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 59

Euphora Drug Coated Balloon – Product Status 59

Euphora Drug Coated Balloon – Product Description 59

Prevail DCB Catheter – Product Status 60

Prevail DCB Catheter – Product Description 60

Medtronic Plc – Ongoing Clinical Trials Overview 61

Prevail DCB Catheter – Drug-Coated Balloon for the Treatment of De Novo and Restenotic Coronary Artery Lesion: a Prospective Observational Study 62

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 63

Rapamycin Drug-Coated Balloon – Product Status 63

Rapamycin Drug-Coated Balloon – Product Description 63

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 64

Limus Drug Coated Balloon – Coronary – Product Status 64

Limus Drug Coated Balloon – Coronary – Product Description 64

Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Virtue Sirolimus-Eluting Balloon – ISR – Product Status 65

Virtue Sirolimus-Eluting Balloon – ISR – Product Description 65

Virtue Sirolimus-Eluting Balloon – Small Vessels – Product Status 66

Virtue Sirolimus-Eluting Balloon – Small Vessels – Product Description 66

Orchestra BioMed Inc – Ongoing Clinical Trials Overview 67

Virtue Sirolimus-Eluting Balloon – ISR – Virtue ISR-US Pivotal Study Evaluating the Efficacy and Safety of Virtue SAB for the Treatment of Patients with Coronary In-stent Restenosis (ISR) 68

QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

Chocolate Touch PTCA Coronary Drug Coated Balloon – Product Status 69

Chocolate Touch PTCA Coronary Drug Coated Balloon – Product Description 69

Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview 70

Rontis Drug Coated Balloon – Product Status 70

Rontis Drug Coated Balloon – Product Description 70

Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

Next-Generation Rapamycin Coronary Balloon Catheter – Product Status 71

Next-Generation Rapamycin Coronary Balloon Catheter – Product Description 71

Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

Rapamycin Coronary Artery Drug Coated Balloon – Product Status 72

Rapamycin Coronary Artery Drug Coated Balloon – Product Description 72

Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

Rapamycin Drug-Loaded Coronary ISR Balloon – Product Status 73

Rapamycin Drug-Loaded Coronary ISR Balloon – Product Description 73

Rapamycin Drug-Loaded Coronary LV Balloon – Product Status 74

Rapamycin Drug-Loaded Coronary LV Balloon – Product Description 74

Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 75

Drug Coated Balloon – In-stent Restenosis (ISR) – Product Status 75

Drug Coated Balloon – In-stent Restenosis (ISR) – Product Description 75

Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 76

Mitomycin-Based DCB – Coronary – Product Status 76

Mitomycin-Based DCB – Coronary – Product Description 76

Paclitaxel-Based Drug Coated Balloon – Coronary – Product Status 77

Paclitaxel-Based Drug Coated Balloon – Coronary – Product Description 77

Glossary 94

Figures

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 11

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory 12

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path 13

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date 14

PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials 15

Frequently asked questions

PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.